for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Fosun Pharmaceutical (Group)

2196.HK

Latest Trade

22.20HKD

Change

0.25(+1.14%)

Volume

1,565,685

Today's Range

21.95

 - 

22.45

52 Week Range

19.76

 - 

31.25

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Shanghai Fosun Pharmaceutical Group Co Enters Into Capital Increase Agreement

Nov 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::CHANCHENG HOSPITAL YOULE INFORMATION AND SHENZHEN FOSUN HEALTH ENTERED INTO CAPITAL INCREASE AGREEMENT.UNDER DEAL, UNIT TO CONTRIBUTE RMB10.4 MILLION TO SUBSCRIBE FOR ADDITIONAL REGISTERED CAPITAL OF SHENZHEN FOSUN HEALTH.

Shanghai Fosun Pharma's Unit Gland Pharma Plans Listing In India's NSE And Bombay Stock Exchange

Nov 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 2196.HK<600196.SS>::SAYS UNIT GLAND PHARMA LTD PLANS LISTING IN INDIA'S NSE AND BOMBAY STOCK EXCHANGE.

Shanghai Fosun Pharma's 9-Month Net Profit Down 1.5% Y/Y

Oct 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS 9-MONTH NET PROFIT DOWN 1.5% Y/Y.

Shanghai Fosun Pharmaceutical Says 9-Month Net Profit Attributable RMB2.06 Bln

Oct 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::9-MONTH OPERATING REVENUE RMB21.23 BILLION VERSUS RMB18.14 BILLION.9-MONTH NET PROFIT ATTRIBUTABLE RMB2.06 BILLION VERSUS RMB2.09 BILLION.

Shanghai Fosun Pharma's Unit Buys 97.0 Mln Shares In Sisram Medical

Sept 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT AMPLE UP WILL BUY 96.98 MILLION SHARES IN SISRAM MEDICAL LTD <<<1696.HK>>> AT HK$4.02 ($0.5127) PER SHARE.

Shanghai Fosun Pharmaceutical Group Says Fosun High Tech Bought 1.1 Mln H Shares

Sept 19 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::FOSUN HIGH TECH BOUGHT 1.1 MILLION H SHARES AT AVERAGE PURCHASE PRICE OF ABOUT HK$22.80 PER H SHARE.FOSUN HIGH TECH INTENDS TO FURTHER INCREASE ITS SHAREHOLDING IN CO (INCLUDING A SHARES AND/OR H SHARES).

Fosun International Says Final Offer Price Of Shanghai Henlius H Shares Is HK$49.60/ Share

Sept 18 (Reuters) - Fosun International Ltd <0656.HK>::FINAL OFFER PRICE OF SHANGHAI HENLIUS H SHARES TO BE ISSUED UNDER GLOBAL OFFERING IS HK$49.60 PER SHANGHAI HENLIUS OFFER SHARE.IF GLOBAL OFFERING PROCEEDS AT FINAL OFFER PRICE, MARKET CAP OF SHANGHAI HENLIUS AFTER COMPLETION TO BE HK$26,740.8 MILLION.INTERNATIONAL UNDERWRITING AGREEMENT FOR INTERNATIONAL OFFERING ENTERED BY SHANGHAI HENLIUS AND UNDERWRITERS OF OFFERING.SHANGHAI HENLIUS IS EXPECTED TO BE LISTED ON MAIN BOARD OF HONG KONG STOCK EXCHANGE ON 25 SEPTEMBER.UNDER INTERNATIONAL AGREEMENT, UNDERWRITERS TO SUBSCRIBE FOR SHANGHAI HENLIUS OFFER SHARES AT HK$49.60 PER SHARE.

Shanghai Fosun Pharmaceutical's H1 Net Profit Down 2.8% Y/Y

Aug 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK ::SAYS H1 NET PROFIT DOWN 2.8% Y/Y.

Shanghai Fosun Pharmaceutical Group To Establish JV

Aug 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::SHANGHAI FOSUN PHARMACEUTICAL GROUP - COMPANY AND SFHIH ENTERED INTO INVESTMENT AGREEMENT IN RELATION TO PROPOSED ESTABLISHMENT OF JV CO.SHANGHAI FOSUN PHARMACEUTICAL GROUP -REGISTERED CAPITAL OF JV COMPANY IS RMB10 MILLION, OF WHICH CO TO MAKE CONTRIBUTION IN AMOUNT OF RMB6 MILLION.

Shanghai Fosun Pharma To Sell Healthy Harmony For About $523.15 Million

July 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS NF UNICORN ACQUISITION L.P. AND NEW FRONTIER CORP AGREE TO BUY HEALTHY HARMONY HOLDINGS L.P. AND HEALTHY HARMONY GP INC FOR ABOUT $523.15 MILLION.SAYS IT EXPECTS TO GAIN 1.65 BILLION YUAN ($239.80 million) FROM THE DEAL, PROCEEDS WILL BE USED TO BOOST WORKING CAPITAL, REPAY DEBTS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up